AAAAAA
Results:
1-8
|
Results: 8
Authors:
Szczeklik, A
Nizankowska, E
Bochenek, G
Nagraba, K
Mejza, F
Swierczynska, M
Citation: A. Szczeklik et al., Safety of a specific COX-2 inhibitor in aspirin-induced asthma, CLIN EXP AL, 31(2), 2001, pp. 219-225
Authors:
Szczeklik, A
Mastalerz, L
Nizankowska, E
Sanak, M
Citation: A. Szczeklik et al., Montelukast for persistent asthma - Reply, LANCET, 358(9291), 2001, pp. 1456-1457
Authors:
Szczeklik, A
Nizankowska, E
Duplaga, M
Citation: A. Szczeklik et al., Natural history of aspirin-induced asthma, EUR RESP J, 16(3), 2000, pp. 432-436
Authors:
Nizankowska, E
Bestynska-Krypel, A
Cmiel, A
Szczeklik, A
Citation: E. Nizankowska et al., Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma, EUR RESP J, 15(5), 2000, pp. 863-869
Authors:
Nizankowska, E
Szczeklik, A
Citation: E. Nizankowska et A. Szczeklik, Asthma and aspirin intolerance, REV MAL RES, 17(1BIS), 2000, pp. 255-264
Authors:
Szczeklik, A
Nizankowska, E
Citation: A. Szczeklik et E. Nizankowska, Clinical features and diagnosis of aspirin induced asthma, THORAX, 55, 2000, pp. S42-S44
Authors:
Cebulska-Wasilewska, A
Wierzewska, A
Nizankowska, E
Graca, B
Hughes, JA
Anderson, D
Citation: A. Cebulska-wasilewska et al., Cytogenetic damage and ras p21 oncoprotein levels from patients with chronic obstructive pulmonary disease (COPD), untreated lung cancer and healthy controls, MUT RES-F M, 431(1), 1999, pp. 123-131
Authors:
Anderson, D
Hughes, JA
Brinkworth, MH
Cebulska-Wasilewska, A
Nizankowska, E
Graca, B
Veidebaum, T
Peltonen, K
Sorsa, M
Citation: D. Anderson et al., Examination of ras oncoproteins in human plasma from healthy controls and workers exposed to petroleum emissions, including benzene-related compounds, MUT RES-GTE, 445(2), 1999, pp. 167-173
Risultati:
1-8
|